{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T03:39:43Z","timestamp":1774323583365,"version":"3.50.1"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,1,1]]},"DOI":"10.2169\/internalmedicine.4752-20","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T22:05:35Z","timestamp":1598047535000},"page":"145-150","source":"Crossref","is-referenced-by-count":12,"title":["Membranous Nephropathy with Proteinase 3-ANCA-associated Vasculitis Successfully Treated with Rituximab"],"prefix":"10.2169","volume":"60","author":[{"given":"Shun","family":"Yoshida","sequence":"first","affiliation":[{"name":"Third Department of Internal Medicine, University of Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichiro","family":"Hanai","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, University of Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Nakagomi","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, University of Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, University of Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, University of Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Furuya","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, University of Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65: 1-11, 2013."},{"key":"2","unstructured":"2. Haas M, Eustace JA. Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int 65: 2145-2152, 2004."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yu F, Chen M, Wang SX, Zou WZ, Zhao MH, Wang HY. Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney. Nephrology (Carlton) 12: 74-80, 2007.","DOI":"10.1111\/j.1440-1797.2006.00713.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Couser WG. Primary membranous nephropathy. Clin J Am Soc Nephrol 12: 983-997, 2017.","DOI":"10.2215\/CJN.11761116"},{"key":"5","unstructured":"5. Fogo AB, Lusco MA, Najafian B, Alpers CE. AJKD atlas of renal pathology: membranous nephropathy. Am J Kidney Dis 66: e15-e17, 2015."},{"key":"6","unstructured":"6. Balafa O, Kalaitzidis R, Liapis G, et al. Crescentic glomerulonephritis and membranous nephropathy: a rare coexistence. Int Urol Nephrol 47: 1373-1377, 2015."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nasr SH, Said SM, Valeri AM, et al. Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis. Clin J Am Soc Nephrol 4: 299-308, 2009.","DOI":"10.2215\/CJN.04060808"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Suwabe T, Ubara Y, Tagami T, et al. Membranous glomerulopathy induced by myeloperoxidase-anti-neutrophil cytoplasmic antibody-related crescentic glomerulonephritis. Intern Med 44: 853-858, 2005.","DOI":"10.2169\/internalmedicine.44.853"},{"key":"9","unstructured":"9. Tse WY, Howie AJ, Adu D, et al. Association of vasculitic glomerulonephritis with membranous nephropathy: a report of 10 cases. Nephrol Dial Transplant 12: 1017-1027, 1997."},{"key":"10","unstructured":"10. Zou R, Liu G, Cui Z, Chen M, Zhao MH. Clinical and immunologic characteristics of patients with ANCA-associated glomerulonephritis combined with membranous nephropathy: a retrospective cohort study in a single Chinese center. Medicine (Baltimore) 94: e1472, 2015."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Falk RJ, Jennette JC. ANCA small-vessel vasculitis. J Am Soc Nephrol 8: 314-322, 1997.","DOI":"10.1681\/ASN.V82314"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Neumann I, Regele H, Kain R, Birck R, Meisl FT. Glomerular immune deposits are associated with increased proteinuria in patients with ANCA-associated crescentic nephritis. Nephrol Dial Transplant 18: 524-531, 2003.","DOI":"10.1093\/ndt\/18.3.524"},{"key":"13","unstructured":"13. Fervenza FC, Appel GB, Barbour SJ, et al. Rituximab or cyclosporine in the treatment of membranous nephropathy. N Engl J Med 381: 36-46, 2019."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Stone JH, Merkel PA, Spiera R, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363: 221-232, 2010.","DOI":"10.1056\/NEJMc1009101"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Jones RB, Tervaert JW, Hauser T, et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363: 211-220, 2010.","DOI":"10.1056\/NEJMoa0909169"},{"key":"16","unstructured":"16. Tominaga K, Uchida T, Imakiire T, et al. Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with detection of myeloperoxidase and phospholipase A2 receptor in membranous nephropathy-lesions: report of two patients with microscopic polyangiitis. BMC Nephrol 19: 120, 2018."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Hanamura K, Tojo A, Kinugasa S, et al. Detection of myeloperoxidase in membranous nephropathy-like deposits in patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Hum Pathol 42: 649-658, 2011.","DOI":"10.1016\/j.humpath.2010.08.020"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hilhorst M, van Paassen P, Tervaert J.W. Proteinase 3-ANCA vasculitis versus myeloperoxidase-ANCA vasculitis. J Am Soc Nephrol 26: 2314-2327, 2015.","DOI":"10.1681\/ASN.2014090903"},{"key":"19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jbspin.2017.05.004","volume":"85","author":"V Witko-Sarsat","year":"2018","unstructured":"19. Witko-Sarsat V, Thieblemont N. Granulomatosis with polyangiitis (Wegener granulomatosis): a proteinase-3 driven disease? Joint Bone Spine 85: 185-189, 2018.","journal-title":"Joint Bone Spine","ISSN":"https:\/\/id.crossref.org\/issn\/1297-319X","issn-type":"print"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kuroki A, Shibata T, Honda H, Totsuka D, Kobayashi K, Sugisaki T. Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy. Intern Med 41: 936-942, 2002.","DOI":"10.2169\/internalmedicine.41.936"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/1\/60_4752-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T11:12:52Z","timestamp":1667992372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/1\/60_4752-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4752-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,1]]}}}